The European Commission has determined that there are no viable alternatives to titanium dioxide (TiO2) as an excipient in many pharmaceutical products. They also identified a risk of shortages if a ...
National Harbor, MD – An EU proposal that, if enacted, would require manufacturers to replace titanium dioxide (TiO2) in medicines would affect millions of patients and more than 90,000 authorized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results